Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Learn more about this revolutionary cancer treatment.
Understand the Basics
Find clinical trials that match your diagnosis, stage and treatment history.
Meet the CRI scientists committed to the development of immunotherapy.
Two leading non-profits combine efforts to accelerate cancer immunotherapy for patients globally
First-of-its-kind analysis of the global immuno-oncology clinical landscape from pre-clinical development to regulatory approval provides unprecedented opportunity to advance the field of immuno-oncology to improve patient care.
Fight Colorectal Cancer, Cancer Research Institute announce Cancer Immunology Research article publication discussing CRC immunotherapy advancement
The Cancer Research Institute announced today that it will honor biotechnology company Genentech and real estate developer and philanthropist Bruce Ratner with the 2017 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Drs. Rafi Ahmed and Thomas F. Gajewski will receive the 2017 William B. Coley Award, and Dr. Shannon Turley will receive the 2017 Frederick W. Alt Award.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in 2018!
Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to fit individual patients